Healthcare technology company Molbio Diagnostics has announced a price band of Rs. 768–807 per share for its upcoming IPO. The company intends to use the funds for expansion, research and development, and strengthening manufacturing capacity. The offering has generated interest because of Molbio’s presence in molecular diagnostics and rapid disease-testing technologies.
The diagnostics sector continues to attract investor attention due to increasing healthcare spending and rising demand for advanced testing solutions. Analysts recommend evaluating the company’s financial performance and long-term growth strategy before investing.
